Moving from theory to research to practice - Implementing an effective dyadic intervention to improve antiretroviral adherence for clinic patients

被引:25
作者
Remien, Robert H.
Stirratt, Michael J.
Dognin, Joanna
Day, Emily
El-Bassel, Nabila
Warne, Patricia
机构
[1] New York State Psychiat Inst & Hosp, HIV Ctr Clin & Behav Studies, New York, NY 10032 USA
[2] Columbia Univ, Sch Social Work, New York, NY 10032 USA
[3] Montefiore Med Ctr, Dept Family & Social Med, Bronx, NY 10467 USA
[4] New Sch Social Res, New York, NY 10011 USA
关键词
antiretroviral adherence; couples; HIV; intervention; social action theory; social support;
D O I
10.1097/01.qai.0000248340.20685.7d
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
There is a dearth of evidence on the relative efficacy of intervention modalities to improve and maintain patient adherence to antiretroviral medications. Although empiric findings from research on HIV/AIDS, other diseases, and chronic medical conditions consistently demonstrate that social support plays an important role in facilitating adherence, few HIV/AIDS interventions have directly targeted this factor. Ewart's social action theory emphasizes the role of social relationships in behavior change and provides a comprehensive and useful guide to the development of interventions for adherence. We describe the development, content, and testing of SMART Couples, an effective antiretroviral adherence intervention that is grounded in social action theory and designed to enhance social support for ART adherence. Finally, we discuss some of the challenges of translating findings from the randomized clinical trial of this intervention into clinical practice and offer recommendations for integration of lessons learned into ongoing clinical care.
引用
收藏
页码:S69 / S78
页数:10
相关论文
共 112 条
[1]   THE THEORY OF PLANNED BEHAVIOR [J].
AJZEN, I .
ORGANIZATIONAL BEHAVIOR AND HUMAN DECISION PROCESSES, 1991, 50 (02) :179-211
[2]   Correlates and predictors of adherence to highly active antiretroviral therapy: Overview of published literature [J].
Ammassari, A ;
Trotta, MP ;
Murri, R ;
Castelli, F ;
Narciso, P ;
Noto, P ;
Vecchiet, J ;
D'Arminio Monforte, A ;
Wu, AW ;
Antinori, A .
JAIDS-JOURNAL OF ACQUIRED IMMUNE DEFICIENCY SYNDROMES, 2002, 31 :S123-S127
[3]   A COMPARATIVE-STUDY OF THE IMPACT OF EDUCATION VS PROCESS GROUPS FOR FAMILIES OF PATIENTS WITH AFFECTIVE-DISORDERS [J].
ANDERSON, CM ;
GRIFFIN, S ;
ROSSI, A ;
PAGONIS, I ;
HOLDER, DP ;
TREIBER, R .
FAMILY PROCESS, 1986, 25 (02) :185-205
[4]  
[Anonymous], 1974, HLTH BELIEF MODEL PE
[5]   Antiretroviral therapy adherence and viral suppression in HIV-infected drug users: Comparison of self-report and electronic monitoring [J].
Arnsten, JH ;
Demas, PA ;
Farzadegan, H ;
Grant, RW ;
Gourevitch, MN ;
Chang, CJ ;
Buono, D ;
Eckholdt, H ;
Howard, AA ;
Schoenbaum, EE .
CLINICAL INFECTIOUS DISEASES, 2001, 33 (08) :1417-1423
[6]  
Bandura A., 1996, SOCIAL FDN THOUGHT A
[7]   Adherence-resistance relationships for protease and non-nucleoside reverse transcriptase inhibitors explained by virological fitness [J].
Bangsberg, DR ;
Acosta, EP ;
Gupta, R ;
Guzman, D ;
Riley, ED ;
Harrigan, PR ;
Parkin, N ;
Deeks, SG .
AIDS, 2006, 20 (02) :223-231
[8]   Modeling the HIV protease inhibitor adherence-resistance curve by use of empirically derived estimates [J].
Bangsberg, DR ;
Porco, TC ;
Kagay, C ;
Charlebois, ED ;
Deeks, SG ;
Guzman, D ;
Clark, R ;
Moss, A .
JOURNAL OF INFECTIOUS DISEASES, 2004, 190 (01) :162-165
[9]   High levels of adherence do not prevent accumulation of HIV drug resistance mutations [J].
Bangsberg, DR ;
Charlebois, ED ;
Grant, RM ;
Holodniy, M ;
Deeks, SG ;
Perry, S ;
Conroy, KN ;
Clark, R ;
Guzman, D ;
Zolopa, A ;
Moss, A .
AIDS, 2003, 17 (13) :1925-1932
[10]   Adherence to protease inhibitors, HIV-1 viral load, and development of drug resistance in an indigent population [J].
Bangsberg, DR ;
Hecht, FM ;
Charlebois, ED ;
Zolopa, AR ;
Holodniy, M ;
Sheiner, L ;
Bamberger, JD ;
Chesney, MA ;
Moss, A .
AIDS, 2000, 14 (04) :357-366